Correction: The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor (PLoS ONE (2013) 8:3 (e59334) DOI: 10.1371/journal.pone.0059334);The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Roth, Bryan L ^a   Gibbons, Simon ^b   Arunotayanun, Warunya ^b   Huang, Xi Ping ^a   Setola, Vincent ^a   Treble, Ric ^c   Iversen, Les ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c LGC   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 (3 METHOXYPHENYL)CYCLOHEXYL]PIPERIDINE; 1 [1 (4 METHOXYPHENYL)CYCLOHEXYL]PIPERIDINE; GLUTAMIC ACID; KETAMINE; METHOXAMINE 2 (ETHYLAMINO) 2 [(3 METHOXYPHENYL)CYCLOHEXANONE]; N ETHYL 1 (3 METHOXYPHENYL)CYCLOHEXANAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE DERIVATIVE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG BINDING; DRUG STRUCTURE; LIGAND BINDING; RADIOASSAY;

EID: 84875100064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194984     Document Type: Erratum

References (27)

1. Corazza O, Schifano F, Simonato P, Fergus S, Assi S, et al. (2012) Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol 27: 145-149.
2. ACMD (2011) Advisory Council on the Misuse of Drugs, Consideration of the Novel Psychoactive Substances ('Legal Highs').
3. ACMD (2012) Advisory Council on the Misuse of Drugs, "Statement of Evidence on Methoxetamine".
4. EMCDDA (2011) (European Monitoring Centre for Drugs and Drug Addiction) Annual Report 2010 & 2011.
5. Morgan CJ, Curran HV, (2012) Ketamine use: a review. Addiction 107: 27-38.
6. Gorelick DA, Wilkins JN, Wong C, (1986) Diagnosis and treatment of chronic phencyclidine (PCP) abuse. NIDA Res Monogr 64: 218-228.
7. Bey T, Patel A, (2007) Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug. Cal J Emerg Med 8: 9-14.
8. Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI, (2011) Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 68: 853-856.
9. Hofer KE, Grager B, Muller DM, Rauber-Luthy C, Kupferschmidt H, et al. (2012) Ketamine-like effects after recreational use of methoxetamine. Ann Emerg Med 60: 97-99.
10. Shields JE, Dargan PI, Wood DM, Puchnarewicz M, Davies S, et al. (2012) Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. Clin Toxicol (Phila) 50: 438-440.
11. Casale J, (2011) 4-Methoxyphencyclidine: an analytical profile. Microgram J 8: 39-42.
12. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, et al. (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 99: 11934-11939.
13. Jensen NH, Rodriguiz RM, Caron MG, Wetsel WC, Rothman RB, et al. (2008) N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology 33: 2303-2312.
14. Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, et al. (2009) Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil. J Pharmacol Exp Ther.
15. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-181.
16. Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, et al. (2003) 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro. Mol Pharmacol 63: 1223-1229.
17. Besnard J, Ruda GF, Setola V, Abecassis K, Rodriguiz RM, et al. (2012) Automated design of ligands to polypharmacological profiles. Nature 492: 215-220.
18. Zarantonello P, Bettini E, Paio A, Simoncelli C, Terreni S, et al. (2011) Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists. Bioorg Med Chem Lett 21: 2059-2063.
19. Moghaddam B, Javitt D (2011) From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment. Neuropsychopharmacology.
20. Javitt DC, (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78: 69-108.
21. Zukin SR, Javitt DC (1991) The brain NMDA receptor, psychotomimetic drug effects, and schizophrenia. In: Tasman A, Goldfinger SM, editors. Review of Psychiatry. Washington,DC: American Psychiatric Press. 480-498.
22. Nishimura F, Sato K, (1999) Ketamine sterochemically inhibits rat brain dopamine transporter. Neurosci Lett 274: 131-134.
23. Chaudieu I, Vignon J, Chicheportiche M, Kamenka JM, Trouiller G, et al. (1989) Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs. Pharmacol Biochem Behav 32: 699-705.
24. Kalir A, Teomy S, Amir A, Fuchs P, Lee SA, et al. (1984) N-allyl analogues of phencyclidine: chemical synthesis and pharmacological properties. J Med Chem 27: 1267-1271.
25. Ahmadi A, Solati J, Hajikhani R, Pakzad S, (2011) Synthesis and analgesic effects of new pyrrole derivatives of phencyclidine in mice. Arzneimittelforschung 61: 296-300.
26. Joannes T, Linders D, Furlano M, Jacobson A, (1994) Lett Drug Des Disc. 7: 79-87.
27. Dolgin E Rapid antidepressant effects of ketamine ignite drug discovery. Nat Med 19: 8.